04:11 PM EDT, 03/19/2026 (MT Newswires) -- Mark Sabag, Executive Vice President, International Markets Commercial, on March 17, 2026, sold 62,102 shares in Teva Pharmaceutical Industries ( TEVA ) for $1,871,816. Following the Form 4 filing with the SEC, Sabag has control over a total of 224,940 ordinary shares of the company, with 224,940 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/818686/000119312526115929/xslF345X05/ownership.xml